Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways

被引:11
|
作者
Therachiyil, Lubna [1 ,2 ]
Hussein, Ola J. [1 ]
Uddin, Shahab [2 ,3 ]
Korashy, Hesham M. [1 ,4 ]
机构
[1] Qatar Univ, Coll Pharm, Dept Pharmaceut Sci, QU Hlth, Doha, Qatar
[2] Hamad Med Corp, Translat Res Inst, Acad Hlth Syst, Doha, Qatar
[3] Hamad Med Corp, Dermatol Inst, Acad Hlth Syst, Doha, Qatar
[4] Qatar Univ, Coll Pharm, Doha, Qatar
关键词
Aryl hydrocarbon receptor; Chemoresistance; Gynecological cancers; Stemness markers; Cancer stem cells; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN OVARIAN-CANCER; SIDE-POPULATION CELLS; BREAST-CANCER; ENDOMETRIAL CANCER; ALDEHYDE DEHYDROGENASE; AH-RECEPTOR; STEM/PROGENITOR CELLS; MULTIDRUG-RESISTANCE; TRANSCRIPTION FACTOR;
D O I
10.1016/j.semcancer.2022.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gynecological malignancies are a female type of cancers that affects the reproductive system. Cancer metastasis or recurrence mediated by cellular invasiveness occurs at advanced stages of cancer progression. Cancer Stem Cells (CSCs) enrichment in tumors leads to chemoresistance, which results in cancer mortality. Exposure to environmental pollutants such as polycyclic aromatic hydrocarbons is associated with an increased the risk of CSC enrichment in gynecological cancers. One of the important pathways that mediates the metabolism and bioactivation of these environmental chemicals is the transcription factor, aryl hydrocarbon receptor (AhR). The present review explores the molecular mechanisms regulating the crosstalk and interaction of the AhR with cancer-related signaling pathways, such as apoptosis, epithelial-mesenchymal transition, immune checkpoints, and G-protein-coupled receptors in several gynecological malignancies such as ovarian, uterine, endometrial, and cervical cancers. The review also discusses the potential of targeting the AhR pathway as a novel chemo-therapy for gynecological cancers.
引用
收藏
页码:1186 / 1202
页数:17
相关论文
共 50 条
  • [41] Regulation and maintenance of cancer stem cells of glioblastoma multiforme: The role of mTOR/MAPK signaling pathways
    Friedman, Marissa D.
    Shannon, Craig M.
    Tobias, Michael
    Braun, Alex
    Murali, Raj
    Jhanwar-Uniya, Meena
    CANCER RESEARCH, 2011, 71
  • [42] Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
    Prud'homme, Gerald J.
    Glinka, Yelena
    Toulina, Anna
    Ace, Olga
    Subramaniam, Venkateswaran
    Jothy, Serge
    PLOS ONE, 2010, 5 (11):
  • [43] Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer
    Giridharan, Madhuvanthi
    Rupani, Vasu
    Banerjee, Satarupa
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 2022 (05) : 193 - 206
  • [44] Targeting signaling pathways involved in metastasis in cancer stem cells
    McCubrey, James A.
    Abrams, Stephen H.
    Chappell, William H.
    Fitzgerald, Timothy L.
    Lertpiriyapong, Kvin
    Polesel, Jerry
    Martelli, Alberto M.
    Cervello, Melchiorre
    Montalto, Giuseppe
    Candido, Saverio
    Libra, Massimo
    Steelman, Linda S.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S40 - S40
  • [45] Signaling pathways governing breast cancer stem cells behavior
    Song, Kai
    Farzaneh, Maryam
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [46] Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways
    Oren, Ohad
    Smith, B. Douglas
    STEM CELL REVIEWS AND REPORTS, 2017, 13 (01) : 17 - 23
  • [47] Controversies in Cancer Stem Cells: Targeting Embryonic Signaling Pathways
    Takebe, Naoko
    Ivy, S. Percy
    CLINICAL CANCER RESEARCH, 2010, 16 (12) : 3106 - 3112
  • [48] Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways
    Ohad Oren
    B. Douglas Smith
    Stem Cell Reviews and Reports, 2017, 13 : 17 - 23
  • [49] Emerging agents that target signaling pathways in cancer stem cells
    Yang, Yue
    Li, Xiaoman
    Wang, Ting
    Guo, Qianqian
    Xi, Tao
    Zheng, Lufeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [50] Drug resistance, signaling pathways: roles for in cancer stem cells?
    McCubrey, James A.
    Chappell, William H.
    Abrams, Stephen
    LeHair, Michele
    Franklin, Richard
    Martelli, Alberto M.
    Stivala, Franca
    Nicoletti, Ferdinando
    Libra, Massimo
    Cervello, Melchiorre
    Steelman, Linda S.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S16 - S16